Breast cancer is a worldwide health concern that affects many people. One key player in this fight is something called oxidative stress. This happens when the body produces too many harmful molecules and struggles to combat them. Picture your body as a battlefield, where these harmful molecules are
Colon cancer is a big deal. It's the third most common cancer in the world. And it's getting worse in countries that are not super rich but not super poor either. This is a problem that needs attention. Let's talk about Asia. It's a huge place with lots of different countries. Some are doin
Lung cancer is a serious and deadly disease. It comes in different types, with non-small cell lung cancer (NSCLC) being the most common. This type of cancer is tricky to treat, especially in advanced stages. Scientists are now looking closely at genes involved in metabolism, especially those that co
Deep breaths can do more than just calm you down. For those fighting left-sided breast cancer, taking a deep breath during radiation therapy can be a game-changer. This technique, known as Deep Inspiratory Breath Hold (DIBH), helps to protect the heart during treatment. But why is this important? We
Prostate cancer screening can be confusing. Sometimes, MRI scans show suspicious areas, but biopsies come back clean. What does this mean for patients? Doctors don't have clear guidelines for follow-ups in these cases. So, what happens next? Researchers wanted to find out the risk of finding signifi
Imagine hospitals and clinics buying drugs at bargain prices, yet billing insurance companies full price. This is the 340B Drug Pricing Program. It's designed to support safety-net hospitals and clinics, but it's also changing how doctors prescribe medicines, especially for breast cancer treatment.
Genomic testing is a big deal in cancer care. It helps spot cancer risks, diagnose issues, and plan treatments. But, getting these tests into everyday healthcare is tough, even when insurance covers them. Insurance companies, or payers, play a huge role in healthcare. They could be key to solving so
Triple negative breast cancer (TNBC) is a challenging type of breast cancer. It's tough to treat because it doesn't respond well to targeted therapies. This is partly due to changes in certain signaling pathways, like the PI3K and mTOR pathways. Researchers have found that a protein called
Glioblastoma, a nasty type of brain tumor, has a sneaky way of communicating with its surroundings. It sends out tiny bubbles, called exosomes, that can change how immune cells, called microglia, behave. These exosomes are like secret messengers, carrying instructions that can turn microglia into he
Biomarkers are like secret codes that our bodies use to send messages about our health. Scientists are always on the hunt for new ways to decode these messages. One exciting area of research is cancer detection. Researchers are looking into things like cfDNA, fecal miRNA, and mitochondrial pathways
